The economic viability of suzetrigine also is a topic of debate. The Institute for Medical and Financial Critique, a nonprofit Corporation that evaluates prescription drug Price-efficiency, has suggested that the drug could be only slightly much more Price-productive than opioids if priced at about $420 weekly.Opioids are sought by drug abusers and